Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Nuclear Medicine and Molecular Imaging
Published in: Nuclear Medicine and Molecular Imaging 6/2018

01-12-2018 | Interesting Image

18F-FDG PET/CT detects Metastatic Renal Cell Carcinoma Masquerading as Primary Breast Malignancy

Authors: Ashwin Singh Parihar, Bhagwant Rai Mittal, Shelvin Kumar Vadi, Rajender Kumar, Kaniyappan Nambiyar, Bishan Radotra, Lileswar Kaman

Published in: Nuclear Medicine and Molecular Imaging | Issue 6/2018

Login to get access

Abstract

We present the case of a 36-year-old woman who underwent 18F-FDG PET/CT with suspicion of a primary breast malignancy. However, PET/CT detected an occult renal cell carcinoma with metastases to the thyroid, breast, lungs and lymph nodes. Thyroid and breast metastases are atypical metastatic sites of renal cell carcinoma. Breast metastases from extra mammary tissue are extremely rare, more so from renal cell carcinoma. Histopathologic confirmation of the breast lesions is imperative to avoid unnecessary mastectomy and imaging can help in raising the suspicion of metastatic involvement versus primary breast malignancy.
Literature
1.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.CrossRef
2.
Brufau BP, Cerqueda CS, Villalba LB, Izquierdo RS, González BM, Molina CN. Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics. 2013;33:1691–716.CrossRef
3.
Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh Q-D, Briganti A, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2012;23:973–80.CrossRef
4.
Sountoulides P, Metaxa L, Cindolo L. Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. J Med Case Rep. 2011;5:429.CrossRef
5.
Bhoil A, Mittal BR, Bhattacharya A, Rane S, Nijhawan R, Gupta V. Renal cell carcinoma presenting as isolated deltoid muscle metastasis 12 years after radical nephrectomy detected on 18F-FDG PET/CT. Clin Nucl Med. 2013;38:e474–6.CrossRef
6.
Pirola GM, Martorana E, Fidanza FA, Bonetti LR, Puliatti S, Bonora A, et al. Rare metastatic sites of renal cell carcinoma: urethra and spermatic cord. Riv Urol. 2016;83:214–7.
7.
Aurangabadkar H, Ali Z. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan. Clin Nucl Med. 2013;38:e471–3.CrossRef
8.
Vassalli L, Ferrari VD, Simoncini E, Rangoni G, Montini E, Marpicati P, et al. Solitary breast metastases from a renal cell carcinoma. Breast Cancer Res Treat. 2001;68:29–31.CrossRef
9.
McLauglin SA, Thiel DD, Smith SL, Wehle MJ, Menke DM. Solitary breast mass as initial presentation of clinically silent metastatic renal cell carcinoma. Breast. 2006;15:426–8.CrossRef
10.
Mahrous M, Al Morsy W, Al-Hujaily A, Al-Sulimani S. Breast metastasis from renal cell carcinoma: rare initial presentation of disease recurrence after 5 years. J Breast Cancer. 2012;15:244–7.CrossRef
11.
Alzaraa A, Vodovnik A, Montgomery H, Saeed M, Sharma N. Breast metastasis from a renal cell cancer. World J Surg Oncol. 2007;5:25.CrossRef
12.
Falco G, Buggi F, Sanna PA, Dubini A, Folli S. Breast metastases from a Renal Cell Carcinoma. A case report and review of the literature. Int J Surg Case Rep. 2014;5:193–5.CrossRef
13.
Kaushik A, Ho L. Thyroid metastasis from primary renal cell cancer on FDG PET/CT. Clin Nucl Med. 2011;36:56–8.CrossRef
Metadata
Title
18F-FDG PET/CT detects Metastatic Renal Cell Carcinoma Masquerading as Primary Breast Malignancy
Authors
Ashwin Singh Parihar
Bhagwant Rai Mittal
Shelvin Kumar Vadi
Rajender Kumar
Kaniyappan Nambiyar
Bishan Radotra
Lileswar Kaman
Publication date
01-12-2018
Publisher
Springer Berlin Heidelberg
Published in
Nuclear Medicine and Molecular Imaging / Issue 6/2018
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-018-0553-6

Other articles of this Issue 6/2018

Nuclear Medicine and Molecular Imaging 6/2018 Go to the issue

Case Report

Evaluation of Hot Nodules of Thyroid Gland Using Tc-99m Pertechnetate: a Novel Approach Using Quantitative Single-Photon Emission Computed Tomography/Computed Tomography

Original Article

Diagnostic Value of 18F-FDG PET/CT and MRI in the Preoperative Evaluation of Uterine Carcinosarcoma

Editorial

Message from the Editor-in-Chief

Review

Brain Theranostics and Radiotheranostics: Exosomes and Graphenes In Vivo as Novel Brain Theranostics

Original Article

FPGA-Based Interface of Digital DAQ System for Double-Scattering Compton Camera

Original Article

Predictive Value of Preoperative Volume-Based 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Parameters in Patients with Resectable Lung Adenocarcinoma